🇺🇸 MRK — Merck & Co., Inc.

Healthcare Compra
← Volver

Precio actual

150,33 USD

Máx. histórico

156,92

10 días

Split 1048:1000 del 03/06/2021

Caída desde máximo

-4,20%

Rango 52 semanas

77,58 – 156,92

Variación hoy

-1,32%

Cierre anterior

152,34

Rango de hoy

150,09 – 152,22

Volumen hoy

4.298.143

Información
Nombre completo
Merck & Co., Inc.
Divisa
USD
Mercado
NYSE
Sector
Healthcare
Industria
Drug Manufacturers - General
Empleados
73.000
PER ⓘ
120,26 (puede no estar actualizado)
Dividend yield
2,23% (puede no estar actualizado)
Precio objetivo analistas
149,50 USD (puede no estar actualizado)
Primera cotización
02/01/1962
Precio actualizado
hace 3 días
Sobre la empresa

Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.

Dividendos repartidos Total últimos 12 meses: 3,3600 USD · Yield: 2,24%
Fecha de pago Importe por participación
03/12/2003 0,3531 USD
03/09/2003 0,3531 USD
20/08/2003 2,7443 USD
04/06/2003 0,3435 USD
05/03/2003 0,3435 USD
04/12/2002 0,3435 USD
04/09/2002 0,3435 USD
05/06/2002 0,3340 USD
06/03/2002 0,3340 USD
05/12/2001 0,3340 USD
30/08/2001 0,3340 USD
31/05/2001 0,3244 USD
07/03/2001 0,3244 USD
06/12/2000 0,3244 USD
30/08/2000 0,3244 USD
Splits Registrados en el histórico de precios
Fecha Ratio
03/06/2021 1048:1000
17/02/1999 2:1
26/05/1992 3:1
26/05/1988 3:1
27/05/1986 2:1
01/06/1972 2:1
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
27/02/1989 9,92 10,02 9,88 9,94 +0,20% 1,40% 3.723.754
24/02/1989 10,10 10,10 9,88 9,92 -1,77% 2,17% 5.602.608
23/02/1989 9,98 10,10 9,92 10,10 +0,40% 1,79% 4.888.291
22/02/1989 10,32 10,32 10,00 10,06 -2,51% 3,08% 4.318.598
21/02/1989 10,38 10,38 10,24 10,32 -0,19% 1,34% 2.807.592
17/02/1989 10,30 10,34 10,26 10,34 +0,39% 0,77% 5.763.581
16/02/1989 10,32 10,36 10,26 10,30 +1,57% 0,96% 6.408.730
15/02/1989 9,96 10,14 9,94 10,14 +1,80% 2,00% 4.294.704
14/02/1989 9,94 10,06 9,94 9,96 +0,60% 1,20% 3.741.989
13/02/1989 9,82 9,94 9,82 9,90 -0,20% 1,21% 5.674.291
10/02/1989 10,08 10,08 9,74 9,92 -1,58% 3,35% 5.882.424
09/02/1989 10,10 10,22 10,02 10,08 -1,17% 1,97% 4.090.344
08/02/1989 10,40 10,50 10,20 10,20 -1,35% 2,87% 4.019.290
07/02/1989 10,24 10,56 10,24 10,34 +0,19% 3,11% 7.250.693
06/02/1989 10,36 10,38 10,10 10,32 -0,57% 2,69% 2.786.842
03/02/1989 10,30 10,38 10,22 10,38 +0,77% 1,54% 3.504.931
02/02/1989 10,26 10,38 10,18 10,30 +0,58% 1,94% 3.967.099
01/02/1989 10,28 10,32 10,18 10,24 -1,34% 1,35% 7.602.821
31/01/1989 10,16 10,40 10,14 10,38 +2,35% 2,54% 5.810.112
30/01/1989 10,22 10,30 10,12 10,14 -1,16% 1,75% 6.133.315
27/01/1989 10,16 10,40 10,10 10,26 +1,37% 2,94% 13.290.946
26/01/1989 9,98 10,16 9,92 10,12 +1,39% 2,39% 5.305.814
25/01/1989 9,94 10,04 9,90 9,98 +1,41% 1,40% 9.311.270
24/01/1989 9,62 9,90 9,60 9,84 +2,06% 3,10% 8.826.466
23/01/1989 9,66 9,70 9,58 9,64 +0,41% 1,23% 5.460.499
20/01/1989 9,70 9,72 9,58 9,60 -0,82% 1,43% 5.268.086
19/01/1989 9,70 9,74 9,54 9,68 +0,20% 2,05% 6.329.501
18/01/1989 9,58 9,66 9,50 9,66 +1,04% 1,66% 5.178.797
17/01/1989 9,62 9,62 9,52 9,56 -0,82% 1,03% 4.846.790
16/01/1989 9,60 9,68 9,60 9,64 +0,41% 0,83% 5.784.960